In this era of cancer genetics, we’ve come to think of cancer as something like a car. Runaway cell proliferation is driven by accelerators, or oncogenes, that are stuck on go—in collusion with...
The challenge posed by Alzheimer disease (AD) is stark: If no means of preventing or delaying AD is identified, the number of Americans suffering from the disease is projected to rise from 5.3...
I t’s a sad fact of modern medicine that many diseases—cancer, Alzheimer’s, Parkinson’s—remain difficult to treat. But for many of the most prevalent disorders, chronic diseases that affect large...
Mapping biochemical information in the brain has the potential to unlock the biochemical processes involved in neuropsychiatric disorders, which remain poorly understood. Although techniques such as...
Researchers who took a fresh look at muscle-invasive bladder cancer through the lens of gene expression discovered that it looks remarkably like breast cancer. This resemblance has important...
The need for new therapies for Alzheimer disease (AD) is urgent: Approximately 5.3 million Americans suffer from AD, and that number is projected to rise to 13 to 16 million by 2050 if no means of...
The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline...
Xiaowei Zhuang couldn’t believe what she was seeing. Utilizing super-resolution microscopy techniques she had developed, Zhuang, a Harvard University biophysicist and chemical biologist, was trying...
The University of Texas MD Anderson Cancer Center will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech, Inc., to develop immunology-based cancer treatments...
TomoTherapy is used at UCLA to treat a wide variety of cancers, but is particularly well suited for challenging cases involving large areas, or when the dose needs to be specially shaped to conform...

Pages